Research study Program year 2025 Source: CMS Open Payments

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter S

Research payments

$6,584,574

2,084 payments

Through program year 2025, $6,584,574 in research payments was reported against A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter S, across 2,084 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$1,080,413	387
2024	Research	$1,470,274	463
2023	Research	$1,499,730	553
2022	Research	$1,482,061	501
2021	Research	$672,267	118
2020	Research	$379,830	62

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $6,584,574 2,084 payments

Who received the money Research payments · program years 2020–2025

NYU School of Medicine Organisation paid for research $899,849 218 payments
US Oncology Research INC Organisation paid for research $845,757 228 payments
US Oncology ResearchLLC Organisation paid for research $528,942 335 payments
Los Angeles Hematology Oncology Medical Group Organisation paid for research $472,004 178 payments
Sarah Cannon Research Institute LLC Organisation paid for research $382,406 144 payments
Memorial Sloan-Kettering Cancer Center Organisation paid for research $310,883 6 payments
US Oncology Research LLC Organisation paid for research $278,185 44 payments
University Of Iowa Organisation paid for research $246,815 93 payments
Rad Consulting LLC Organisation paid for research $211,152 19 payments
University Of Massachusetts Organisation paid for research $176,920 70 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.